Searched for
GVK BIO
Global PE funds eye stake in GVK Bio, co valued at $800 mnIn this proposed transaction, GVK BIO- promoted by the GVK Group and DS Brar, the former CEO and managing director of Ranbaxy Laboratories,...- Government panel looking into GVK Bio data issue, says officialThe concerns raised by French drug regulator ANSM over the data integrity of GVK Bio have no basis, a senior official said.
- GVK Bio extends partnership with Akaal PharmaGVK Bio has extended its tie-up with Australia's Akaal Pharma for scale-up of its novel topical AKP-11 ointment to support Phase II clinica...
- Swedish pharma firm Medivir partners GVK Bio for drug researchThis is the first pact the city-based clinical research the company has inked after it got involved in regulatory issues with European Medi...
- Clients desert GVK Bio after goof-up over clinical trialAfter the alerts by the European regulators in August, GVK Bio could not win a single order and in fact saw its clients cancelling at least.
- European Union health regulators suspect manipulation by GVK BioRegulators in many European countries including Germany are reportedly evaluating whether to suspend the use of over 100 medicines.
- GVK Bio manipulated clinical trials of generic drugs: ReportsThe Federal Institute for Medicines and Medical Products, which issues the licences in Germany, confirmed it has been investigating the all...
- GVK Biosciences to buy Chennai based Vanta Bio for $5millionVanta Bio is into offering toxicology evaluation services for pharmaceutical, biotech, food supplements and feed additives industries.
- GVK Bio under scanner of European Drug RegulatorThe review of medicines for which studies have been conducted by GVK Bio has been initiated at the request of the European Commission.
- GVK Bio under scanner of European Drug RegulatorThe review of medicines for which studies have been conducted by GVK Bio has been initiated at the request of the European Commission.
- NanoHealth ties up with GVK BIO for healthcare servicesNanoHealth CEO Manish Ranjan said the mission is to prevent premature deaths caused due to chronic diseases in urban slums.
- GVK BIO unveils new brand, aims to be among top 3 Asian firmsGVK Biosciences (GVK BIO), which unveiled a new brand, today said it aims to be among the top three clinical research organisations in Asia...
- Sequoia plans to sell its 20% stake in GVK Biosciences“The fund is looking at earning over three times returns on its investment in GVK Bio. Currently, its stake is being valued at around Rs 31...
- GVK BIO signs pact with US-based Aragen Bioscience Inc for acquisitionGVK BIO, a leading small-molecule Contract Research Organisation (CRO) today announced that it signed an agreement to acquire Aragen Biosci...
- GVK Biosciences and Onconova Therapeutics to develop new drugs for cancer jointlyThe joint partnership will be based in the US and will align research priorities and tech expertise from both companies.
- GVK BIO selected as preferred provider for 14 global PDPsDrug discovery research and development organisation GVK Biosciences has been selected as a preferred provider to a consortium of 14 global...
- GVK forays into clinical trials with Chinese coHyderabad-based GVK Biosciences has tied up with Excel PharmaStudies, a Chinese clinical research organisation, to conduct clinical trials ...
- GVK Biosciences and CRELUX set up drug discovery platformGVK Biosciences and CRELUX have set-up a highly robust fragment-based drug discovery platform proven to deliver rapidly, viable lead molecu...
- GVK Bio eyes 100-cr PE dealGVK Bio, a provider of contract research services for pharmaceutical and biotechnology companies, expects to raise Rs 100 crore in private ...
- GVK Bio appoints Manni Kantipudi as PresidentPremier contract research company GVK Bioscience on Thursday appointed Manni Kantipudi, former chief information officer of Intel corporati...
Load More
